The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

被引：0

作者：

Sharmin, Sifat ^{[1
,2
]}

Roos, Izanne ^{[1
,3
]}

Simpson-Yap, Steve ^{[1
,4
,5
]}

Malpas, Charles ^{[1
,3
]}

Lechner-Scott, Jeannette ^{[6
]}

Buzzard, Katherine ^{[7
]}

Skibina, Olga ^{[7
]}

van der Walt, Anneke ^{[8
]}

Butzkueven, Helmut ^{[8
]}

Kermode, Allan ^{[9
]}

Butler, Ernest ^{[10
]}

Barnett, Michael ^{[10
]}

Hodgkinson, Suzanne ^{[11
]}

McCombe, Pamela ^{[12
,13
,14
]}

Taylor, Bruce ^{[15
]}

Slee, Mark ^{[16
]}

Macdonell, Richard ^{[17
]}

Garber, Justin ^{[18
]}

Shaw, Cameron ^{[19
]}

Shuey, Neil ^{[20
]}

Massey, Jennifer ^{[21
]}

Hardy, Todd ^{[22
]}

Parratt, John ^{[23
]}

Kalincik, Tomas ^{[1
,3
]}

机构：

[1] Univ Melbourne, Dept Med, CORe, Melbourne, Australia

[2] Royal Melbourne Hosp, Dept Neurol, Neuroimmunol Ctr, Melbourne, Australia

[3] Royal Melbourne Hosp, Dept Neurol, Melbourne MS Ctr, Melbourne, Australia

[4] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Australia

[5] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia

[6] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, Australia

[7] Box Hill Hosp, Dept Neurol, Melbourne, Australia

[8] Alfred Hosp, Dept Neurol, Melbourne, Australia

[9] Univ Western Australia, Perron Inst, Nedlands, Australia

[10] Monash Med Ctr, Melbourne, Australia

[11] Brain & Mind Ctr, Sydney, NSW, Australia

[12] Liverpool Hosp, Sydney, Australia

[13] Univ Queensland, Brisbane, Australia

[14] Royal Brisbane & Womens Hosp, Brisbane, Australia

[15] Royal Hobart Hosp, Hobart, Australia

[16] Flinders Univ S Australia, Adelaide, SA, Australia

[17] Austin Hlth, Melbourne, Australia

[18] Westmead Hosp, Sydney, Australia

[19] Geelong Hosp, Geelong, Australia

[20] St Vincents Hosp, Fitzroy, Australia

[21] St Vincents Hosp Sydney, Sydney, Australia

[22] Concord Repatriat Gen Hosp, Sydney, Australia

[23] Royal North Shore Hosp, Sydney, Australia

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 04期

关键词：

secondary progressive multiple sclerosis; disease modifying therapy; latitude; geography; health expenditure;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：6 / 6

页数：1

共 50 条

[31] Spinal myoclonus in secondary progressive multiple sclerosis
Raisa, N.
MOVEMENT DISORDERS, 2021, 36 : S118 - S118
[32] Secondary Progressive Multiple Sclerosis New Insights
Cree, Bruce A. C.
Arnold, Douglas L.
Chataway, Jeremy
Chitnis, Tanuja
Fox, Robert J.
Ramajo, Angela Pozo
Murphy, Niamh
Lassmann, Hans
NEUROLOGY, 2021, 97 (08) : 378 - 388
[33] Macrophage Recruitment in Secondary Progressive Multiple Sclerosis
Hanael, Erez
Rothmann, Tali
Falb, Rina
Gurevich, Michael
Achiron, Anat
NEUROLOGY, 2012, 78
[34] Siponimod: A Review in Secondary Progressive Multiple Sclerosis
Scott, Lesley J.
CNS DRUGS, 2020, 34 (11) : 1191 - 1200
[35] Parkinsonism secondary to primary progressive multiple sclerosis
Gallardo, M.
Soto, A.
MOVEMENT DISORDERS, 2010, 25 (07) : S498 - S498
[36] Management of secondary-progressive multiple sclerosis
Giovannoni, G
CNS DRUGS, 2004, 18 (10) : 653 - 669
[37] Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview
Floriana De Angelis
Domenico Plantone
Jeremy Chataway
CNS Drugs, 2018, 32 : 499 - 526
[38] Fatigue and motivation in secondary progressive multiple sclerosis
Tacchino, A.
Ponzio, M.
Podda, J.
Pedulla, L.
Crivelli, D.
Battaglia, M. A.
Bove, M.
Brichetto, G.
Balconi, M.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 635 - 635
[39] Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview
De Angelis, Floriana
Plantone, Domenico
Chataway, Jeremy
CNS DRUGS, 2018, 32 (06) : 499 - 526
[40] Siponimod for the treatment of secondary progressive multiple sclerosis
Dumitrescu, Laura
Constantinescu, Cris S.
Tanasescu, Radu
EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 143 - 150

← 1 2 3 4 5 →